News

Tue, 06/17/2025

International Consuls Visit KU

Consuls general from Brazil, Ireland, the Czech Republic, Taiwan, Mexico, and Germany recently visited the University of Kansas, where they were greeted by Governor Laura Kelly and Chancellor Douglas Girod. During their trip, they learned about new medical diagnostic tools from the Soper Research Group, heard about vaccine development from...

Wed, 01/15/2020

Urgent Delivery: With global partners, KU researchers formulate life-saving vaccines to be dispatched around the world (KU Alumni Magazine) (Opens in new window)

Thu, 12/12/2019

KU Researchers Launch Center Focused on Advanced Vaccines for the Developing World

In the global health community, they call it “the last mile.” A vaccine’s journey from manufacturer to a child in the developing world takes it through a complex, refrigerated “cold chain” designed to preserve its medicinal value during shipment and storage. To then reach remote villages, vaccines might have to travel through dense jungles, over hot deserts and across large bodies of water. This final leg of the journey, referred to as the “last mile,” can expose vaccines to harsh conditions that compromise their potency and efficacy.
Tue, 03/28/2017

Grant Creates International Partnership, Development of Low-Cost Vaccine

LAWRENCE — The University of Kansas, the Massachusetts Institute of Technology (MIT) and University College London (UCL) have received a $17.6 million Grand Challenge grant from the Bill & Melinda Gates Foundation (BMGF) to develop and produce a low-cost vaccine manufacturing platform for use in developing countries. ...

Tue, 09/01/2015

Pharmaceutical Chemistry Researcher Earns Inaugural Ronald T. Borchardt Professorship

LAWRENCE — Distinguished Professor David Volkin of the Department of Pharmaceutical Chemistry has earned the inaugural Ronald T. Borchardt Professorship, the University of Kansas School of Pharmacy has announced this week. ...